CAS 97281-45-3
:Phosphatidylcholines, egg, hydrogenated
Description:
Phosphatidylcholines, egg, hydrogenated, identified by CAS number 97281-45-3, is a phospholipid derived from egg yolk that has undergone hydrogenation to enhance its stability and shelf life. This substance is characterized by its amphiphilic nature, possessing both hydrophilic (water-attracting) and hydrophobic (water-repelling) properties, which makes it an essential component in biological membranes. Hydrogenation typically results in a more saturated fatty acid profile, which can influence the fluidity and functionality of the lipid. Phosphatidylcholines are known for their role in cell membrane structure, signaling, and as emulsifiers in food and pharmaceutical applications. They are also utilized in cosmetic formulations due to their skin-conditioning properties. The hydrogenated form may exhibit improved oxidative stability compared to its non-hydrogenated counterpart, making it suitable for various industrial applications. Overall, phosphatidylcholines, egg, hydrogenated, is valued for its versatility and functional properties in both biological and commercial contexts.
Formula:Unspecified
Synonyms:- Phosphatidylcholines, egg, hydrogenated
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
L-α-phosphatidylcholine, hydrogenated (Egg, Chicken)
CAS:Formula:C42H86NO7PPurity:99%Color and Shape:SolidMolecular weight:748.1085L-±-phosphatidylcholine, hydrogenated (Egg, Chicken)
CAS:<p>L-±-phosphatidylcholine is a fatty acid that is found in the membranes of cells. It is also a component of liposomes, which are spheres made of phospholipids. L-±-Phosphatidylcholine has been shown to have an inhibitory effect on the activity of toll-like receptor 4 (TLR4) and TLR2, which are innate immune receptors that recognize bacterial cell wall components and activate inflammatory responses. L-±-Phosphatidylcholine has been shown to inhibit the growth of Gram-negative bacteria such as Pseudomonas aeruginosa and Klebsiella pneumoniae, as well as Gram-positive bacteria such as Staphylococcus aureus, methicillin resistant S. aureus (MRSA), and Enterococcus faecalis. This drug also inhibits the expression of proinflammatory cytokines through inhibition of NFκB activation.</p>Formula:PredominantSpeciesPurity:Min. 95%Molecular weight:779.76 g/mol
